These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8542396)
1. Herpes simplex virus latency in tissue culture cells. Preston CM; Russell J; Harris RA; Jamieson DR Gene Ther; 1994; 1 Suppl 1():S49-50. PubMed ID: 8542396 [TBL] [Abstract][Full Text] [Related]
2. Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants. Jamieson DR; Robinson LH; Daksis JI; Nicholl MJ; Preston CM J Gen Virol; 1995 Jun; 76 ( Pt 6)():1417-31. PubMed ID: 7782770 [TBL] [Abstract][Full Text] [Related]
3. The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems. Tal-Singer R; Pichyangkura R; Chung E; Lasner TM; Randazzo BP; Trojanowski JQ; Fraser NW; Triezenberg SJ Virology; 1999 Jun; 259(1):20-33. PubMed ID: 10364486 [TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
5. The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1. Mador N; Panet A; Steiner I J Neurovirol; 2002 Dec; 8 Suppl 2():97-102. PubMed ID: 12491159 [TBL] [Abstract][Full Text] [Related]
6. Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16. Preston CM; McFarlane M Virology; 1998 Sep; 249(2):418-26. PubMed ID: 9791032 [TBL] [Abstract][Full Text] [Related]
7. Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits. O'Brien WJ; Tsao LS; Taylor JL Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1847-53. PubMed ID: 9727407 [TBL] [Abstract][Full Text] [Related]
8. Involvement of cellular death signals in the reactivation of herpes simplex virus type 1 and lambda bacteriophage from a latent state. Panet A; Braun E; Honigman A; Steiner I J Theor Biol; 2005 Sep; 236(1):88-94. PubMed ID: 15967186 [TBL] [Abstract][Full Text] [Related]
9. Incorporation of nuclear matrix attachment regions into the herpes simplex virus type 1 genome does not induce long-term expression of a foreign gene during latency. Makarova O; Gorneva G; Wu F; Farutin V; Villeponteau B; Poliani L; Fink D; Levine M Gene Ther; 1996 Sep; 3(9):829-33. PubMed ID: 8875233 [TBL] [Abstract][Full Text] [Related]
10. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors. Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the Super Elongation Complex Suppresses Herpes Simplex Virus Immediate Early Gene Expression, Lytic Infection, and Reactivation from Latency. Alfonso-Dunn R; Arbuckle JH; Vogel JL; Kristie TM mBio; 2020 Jun; 11(3):. PubMed ID: 32518191 [TBL] [Abstract][Full Text] [Related]
12. Expression of the first 811 nucleotides of the herpes simplex virus type 1 latency-associated transcript (LAT) partially restores wild-type spontaneous reactivation to a LAT-null mutant. Drolet BS; Perng GC; Villosis RJ; Slanina SM; Nesburn AB; Wechsler SL Virology; 1999 Jan; 253(1):96-106. PubMed ID: 9887322 [TBL] [Abstract][Full Text] [Related]
13. [Establishment of a cell model system of herpes simplex virus type II latent infection and reactivation in SH-SY5Y cells]. Sun Z; Yang H; Shi Y; Wei M; Xian J; Hu W Wei Sheng Wu Xue Bao; 2010 Jan; 50(1):98-106. PubMed ID: 20344947 [TBL] [Abstract][Full Text] [Related]
14. Establishment of latency in vitro by the herpes simplex virus type 1 mutant in1814. Harris RA; Preston CM J Gen Virol; 1991 Apr; 72 ( Pt 4)():907-13. PubMed ID: 1849973 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific. Nicholl MJ; Preston CM J Virol; 1996 Sep; 70(9):6336-9. PubMed ID: 8709261 [TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus genes involved in latency in vitro. Russell J; Stow ND; Stow EC; Preston CM J Gen Virol; 1987 Dec; 68 ( Pt 12)():3009-18. PubMed ID: 2826646 [TBL] [Abstract][Full Text] [Related]
17. An in vitro latency system for herpes simplex virus type 2. Russell J; Preston CM J Gen Virol; 1986 Feb; 67 ( Pt 2)():397-403. PubMed ID: 3003243 [TBL] [Abstract][Full Text] [Related]
18. De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. Thompson RL; Preston CM; Sawtell NM PLoS Pathog; 2009 Mar; 5(3):e1000352. PubMed ID: 19325890 [TBL] [Abstract][Full Text] [Related]
19. VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo. Sawtell NM; Triezenberg SJ; Thompson RL J Neurovirol; 2011 Dec; 17(6):546-51. PubMed ID: 22144074 [TBL] [Abstract][Full Text] [Related]
20. Roles of the nuclear lamina in stable nuclear association and assembly of a herpesviral transactivator complex on viral immediate-early genes. Silva L; Oh HS; Chang L; Yan Z; Triezenberg SJ; Knipe DM mBio; 2012; 3(1):. PubMed ID: 22251972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]